Education
About Us
Working with TipRanks
Follow Us
Novabay Pharmaceuticals (NBY)
XASE:NBY
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 9.78M | $ 10.46M | $ 14.40M | $ 10.20M | $ 9.93M |
| Gross Profit | $ 6.48M | $ 6.08M | $ 7.78M | $ 6.51M | $ 5.96M |
| Operating Income | $ -5.84M | $ -4.10M | $ -14.42M | $ -8.86M | $ -6.43M |
| EBITDA | $ -5.92M | $ -4.09M | $ -7.20M | $ -8.74M | $ -6.38M |
| Net Income | $ -7.22M | $ -9.64M | $ -10.61M | $ -5.82M | $ -11.04M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 430.00K | $ 3.13M | $ 5.36M | $ 7.50M | $ 11.95M |
| Total Assets | $ 3.42M | $ 9.03M | $ 16.40M | $ 23.98M | $ 15.24M |
| Total Debt | $ 1.67M | $ 2.74M | $ 2.04M | $ 551.00K | $ 503.00K |
| Net Debt | $ 1.24M | $ -390.00K | $ -3.32M | $ -6.95M | $ -11.45M |
| Total Liabilities | $ 3.55M | $ 5.72M | $ 5.84M | $ 13.81M | $ 2.92M |
| Stockholders' Equity | $ -129.00K | $ 3.31M | $ 10.55M | $ 10.17M | $ 12.32M |
| Cash Flow | |||||
| Free Cash Flow | $ -5.19M | $ -4.28M | $ -6.77M | $ -9.24M | $ -4.75M |
| Operating Cash Flow | $ -5.18M | $ -4.26M | $ -6.65M | $ -9.19M | $ -4.72M |
| Investing Cash Flow | $ 1.06M | $ -19.00K | $ -112.00K | $ -12.04M | $ -26.00K |
| Financing Cash Flow | $ 1.50M | $ 1.91M | $ 4.63M | $ 16.79M | $ 9.76M |